CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cognito Therapeutics, a neurotechnology company advancing disease-modifying therapies to treat CNS diseases, announced today a $73M Series B financing round led by ...
According to the owner of the venue, the "audience thought it was part of his set" A stand-up comedian died onstage during a performance Thursday evening. Ian Cognito, a British comic, fell ill during ...
Results from OVERTURE showed Spectris preserved white matter and myelin integrity across multiple brain regions, indicating structural neuroprotection. The OVERTURE study demonstrated that Spectris ...
Image caption: Cognito Spectris investigational device. Image credit: Cognito Therapeutics Image caption: Cognito Spectris investigational device. Image credit: Cognito Therapeutics By merging ...
Cognito Therapeutics, a company using visual and auditory stimulation to treat neurodegenerative disorders, announced it closed an oversubscribed $105 million Series C funding round. Morningside ...
Add Yahoo as a preferred source to see more of our stories on Google. British comedian Ian Cognito died performing a stand-up routine Thursday at the Atic bar in Bicester, England; however, according ...
According to the study, improvements were particularly pronounced in the entorhinal region of the brain, where the Cognito headset users saw white matter increase by more than 5%, compared to a 7.6% ...
During the 12-month Hope study, participants will undergo a series of assessments to determine whether Cognito's technology helps to slow or stop the progression of Alzheimer's. The newly launched ...
CAMBRIDGE, Mass. & NEW YORK--(BUSINESS WIRE)--Cognito Therapeutics, a pioneer in developing disease-modifying therapeutic interventions for neurodegenerative diseases, and Aetion, a global real-world ...
New data from Cognito Therapeutics has indicated that its Spectris device increases cerebrospinal fluid (CSF) HDL-like lipid transport particles, suggesting the neuromodulation therapy prompts a ...
Forbes contributors publish independent expert analyses and insights. I’m an analyst covering neurotech's impact on business and society. This voice experience is generated by AI. Learn more. This ...
Cognito Therapeutics, a late clinical-stage neurotechnology company developing non-invasive therapies for neurodegenerative diseases, announced the close of an oversubscribed $105 million Series C ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results